| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |